257 related articles for article (PubMed ID: 23882125)
21. The significantly enhanced frequency of functional CD4+CD25+Foxp3+ T regulatory cells in therapeutic dose aspirin-treated mice.
Javeed A; Zhang B; Qu Y; Zhang A; Sun C; Zhang L; Liu J; Zeng C; Zhao Y
Transpl Immunol; 2009 Mar; 20(4):253-60. PubMed ID: 19146957
[TBL] [Abstract][Full Text] [Related]
22. Recent thymic origin, differentiation, and turnover of regulatory T cells.
Mabarrack NH; Turner NL; Mayrhofer G
J Leukoc Biol; 2008 Nov; 84(5):1287-97. PubMed ID: 18682578
[TBL] [Abstract][Full Text] [Related]
23. Function of the IL-2R for thymic and peripheral CD4+CD25+ Foxp3+ T regulatory cells.
Bayer AL; Yu A; Malek TR
J Immunol; 2007 Apr; 178(7):4062-71. PubMed ID: 17371960
[TBL] [Abstract][Full Text] [Related]
24. The origin of thymic CD4+CD25+ regulatory T cells and their co-stimulatory requirements are determined after elimination of recirculating peripheral CD4+ cells.
Zhan Y; Bourges D; Dromey JA; Harrison LC; Lew AM
Int Immunol; 2007 Apr; 19(4):455-63. PubMed ID: 17314081
[TBL] [Abstract][Full Text] [Related]
25. Interplay between mTOR and STAT5 signaling modulates the balance between regulatory and effective T cells.
Shan J; Feng L; Sun G; Chen P; Zhou Y; Xia M; Li H; Li Y
Immunobiology; 2015 Apr; 220(4):510-7. PubMed ID: 25468562
[TBL] [Abstract][Full Text] [Related]
26. Changes of regulatory T cells and FoxP3 gene expression in the aging process and its relationship with lung tumors in humans and mice.
Pan XD; Mao YQ; Zhu LJ; Li J; Xie Y; Wang L; Zhang GB
Chin Med J (Engl); 2012 Jun; 125(11):2004-11. PubMed ID: 22884069
[TBL] [Abstract][Full Text] [Related]
27. TGF-beta1 modulates Foxp3 expression and regulatory activity in distinct CD4+ T cell subsets.
Pyzik M; Piccirillo CA
J Leukoc Biol; 2007 Aug; 82(2):335-46. PubMed ID: 17475784
[TBL] [Abstract][Full Text] [Related]
28. Effects of hypertonic saline on CD4+CD25+Foxp3+ regulatory T cells after hemorrhagic shock in relation to iNOS and cytokines.
Isayama K; Murao Y; Saito F; Hirakawa A; Nakatani T
J Surg Res; 2012 Jan; 172(1):137-45. PubMed ID: 20888597
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of alanyl-aminopeptidase on CD4+CD25+ regulatory T-cells enhances expression of FoxP3 and TGF-beta1 and ameliorates acute colitis in mice.
Bank U; Tadje J; Täger M; Wolke C; Bukowska A; Ittenson A; Reinhold D; Helmuth M; Ansorge S; Shakespeare A; Vieth M; Malfertheiner P; Naumann M; Lendeckel U
Int J Mol Med; 2007 Oct; 20(4):483-92. PubMed ID: 17786278
[TBL] [Abstract][Full Text] [Related]
30. Increased numbers and suppressive activity of regulatory CD25(+)CD4(+) T lymphocytes in the absence of CD4 engagement by MHC class II molecules.
Shen X; Niu C; König R
Cell Immunol; 2013 Apr; 282(2):117-28. PubMed ID: 23770721
[TBL] [Abstract][Full Text] [Related]
31. The Wiskott-Aldrich syndrome protein is required for the function of CD4(+)CD25(+)Foxp3(+) regulatory T cells.
Maillard MH; Cotta-de-Almeida V; Takeshima F; Nguyen DD; Michetti P; Nagler C; Bhan AK; Snapper SB
J Exp Med; 2007 Feb; 204(2):381-91. PubMed ID: 17296786
[TBL] [Abstract][Full Text] [Related]
32. Contribution of CD4+CD25+ T cells to the regression phase of experimental autoimmune uveoretinitis.
Sun M; Yang P; Du L; Zhou H; Ren X; Kijlstra A
Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):383-9. PubMed ID: 19696173
[TBL] [Abstract][Full Text] [Related]
33. Rapamycin, not cyclosporine, permits thymic generation and peripheral preservation of CD4+ CD25+ FoxP3+ T cells.
Coenen JJ; Koenen HJ; van Rijssen E; Kasran A; Boon L; Hilbrands LB; Joosten I
Bone Marrow Transplant; 2007 May; 39(9):537-45. PubMed ID: 17351648
[TBL] [Abstract][Full Text] [Related]
34. Foxp3-dependent and -independent molecules specific for CD25+CD4+ natural regulatory T cells revealed by DNA microarray analysis.
Sugimoto N; Oida T; Hirota K; Nakamura K; Nomura T; Uchiyama T; Sakaguchi S
Int Immunol; 2006 Aug; 18(8):1197-209. PubMed ID: 16772372
[TBL] [Abstract][Full Text] [Related]
35. Increased CD4+CD25+Foxp3+ regulatory T cells in tolerance induced by portal venous injection.
He F; Chen Z; Xu S; Cai M; Wu M; Li H; Chen X
Surgery; 2009 Jun; 145(6):663-74. PubMed ID: 19486771
[TBL] [Abstract][Full Text] [Related]
36. No alterations in the frequency of FOXP3+ regulatory T-cells in type 1 diabetes.
Brusko T; Wasserfall C; McGrail K; Schatz R; Viener HL; Schatz D; Haller M; Rockell J; Gottlieb P; Clare-Salzler M; Atkinson M
Diabetes; 2007 Mar; 56(3):604-12. PubMed ID: 17327427
[TBL] [Abstract][Full Text] [Related]
37. Natural killer cells prevent CD28-mediated Foxp3 transcription in CD4+CD25- T lymphocytes.
Brillard E; Pallandre JR; Chalmers D; Ryffel B; Radlovic A; Seilles E; Rohrlich PS; Pivot X; Tiberghien P; Saas P; Borg C
Exp Hematol; 2007 Mar; 35(3):416-25. PubMed ID: 17309822
[TBL] [Abstract][Full Text] [Related]
38. Lower proportions of CD4+CD25(high) and CD4+FoxP3, but not CD4+CD25+CD127(low) FoxP3+ T cell levels in children with autoimmune thyroid diseases.
Bossowski A; Moniuszko M; Dąbrowska M; Sawicka B; Rusak M; Jeznach M; Wójtowicz J; Bodzenta-Lukaszyk A; Bossowska A
Autoimmunity; 2013 May; 46(3):222-30. PubMed ID: 23249428
[TBL] [Abstract][Full Text] [Related]
39. Detection of CD4+ CD25+ FOXP3+ regulatory T cells in peripheral blood of patients with chronic autoimmune urticaria.
Sun RS; Sui JF; Chen XH; Ran XZ; Yang ZF; Guan WD; Yang T
Australas J Dermatol; 2011 Aug; 52(3):e15-8. PubMed ID: 21834806
[TBL] [Abstract][Full Text] [Related]
40. Characterization of CD4+ FOXP3+ T-cell clones established from chronic inflammatory lesions.
Okui T; Ito H; Honda T; Amanuma R; Yoshie H; Yamazaki K
Oral Microbiol Immunol; 2008 Feb; 23(1):49-54. PubMed ID: 18173798
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]